US 10227362
Anti-pulmonary tuberculosis nitroimidazole derivative
granted A61KA61K31/437A61K31/4375
Quick answer
US patent 10227362 (Anti-pulmonary tuberculosis nitroimidazole derivative) held by Medshine Discovery Inc. expires Mon Mar 07 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Medshine Discovery Inc.
- Grant date
- Tue Mar 12 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Mar 07 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 11
- CPC classes
- A61K, A61K31/437, A61K31/4375, A61K31/4545, A61K31/4985